MC

Miami Cancer Institute at IDWeek 2026

Oct 21–24, 2026 Washington, DC ~12k attendees Website

Miami Cancer Institute brings 2 presentations to IDWeek 2026 in Washington. Its program centres on infections and antifungal use in people with cancer. One study reviews inpatient isavuconazole prescribing, and another tracks infectious complications after bispecific antibody therapy for multiple myeloma.

OrganizationIDWeek 2026 Attendance
MC
Miami Cancer Institute
Miami, FL
Poster
Fri Oct 23
12:15pm–1:30pm
Evaluation of Inpatient Isavuconazole Prescribing Practices at a Community‑Based Cancer Center
Poster Hall B-C · Poster P-1922
S4. Antibiotic Stewardship: Special Populations
Poster
Fri Oct 23
12:15pm–1:30pm
Infectious Complications After Bispecific Antibody Therapy in Multiple Myeloma at a Community‑Based Cancer Center
Poster Hall B-C · Poster P-2044
T3. Studies of the epidemiology of infections in transplant patients and patients with impaired immunity due to underlying disease or immunosuppressive drugs

Explore the full IDWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full IDWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Miami Cancer Institute

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction